推薦產品
描述
Powered by Eupheria Biotech
產品線
MISSION®
形狀
lyophilized powder
esiRNA cDNA 標靶序列
GCAACCACAAGTCCAATGTGATCAGGAAGAAACAGGTCCACCTCGAATTGGCTGTTACCATATCTCAACAGAAAACACGGAGAATTCGAAATTCGACGGGATTAAAGGACGCGTGAAAGGTTTGAGAGAAGAGAGATGCCGCTATTGAATCTGCTGGAGTTTTACATCCCAAGATGAAGACAGCATTCAGAATTGATGTGATTTCCTTGAATCGTGGCTTAGGAAATGTGGACACTTAAAACTCTCACTTGAAATTGGGCACAGGTTTGATGTAGAGATAAGGACGGGGTGCGGAATGGAGACCCATTTTGTCATTGATTCATCTGACCGATAAGGCCATAGTGCAGTTAGGTGATATTCGAAAGCTTCTTTGATGCTCTTTATGTATATGTTGGAAGGAACTACCAGGCGTTG
Ensembl | 小鼠類登錄號
NCBI登錄號
運輸包裝
ambient
儲存溫度
−20°C
基因資訊
mouse ... CD24A(12484) , Cd24a(12484)
一般說明
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
法律資訊
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
10 - Combustible liquids
閃點(°F)
Not applicable
閃點(°C)
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
Human molecular genetics, 24(17), 4971-4983 (2015-06-18)
RNA interference (RNAi) offers a promising therapeutic approach for dominant genetic disorders that involve gain-of-function mechanisms. One candidate disease for RNAi therapy application is myotonic dystrophy type 1 (DM1), which results from toxicity of a mutant mRNA. DM1 is caused
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務